Patents by Inventor Jiankang Liu

Jiankang Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240117470
    Abstract: A high-thermal conductivity composite material is AlNp/ZA27 composite material, including 2%, 4%, 6%, or 8% by volume of aluminum nitride (AlN) ceramic particles and zinc-aluminium-27 (ZA27) alloy. The ZA27 alloy includes 70.52-71.08% by weight of Zn, 25.58˜27.65% by weight of Al, 1.27˜3.45% by weight of Cu, and 0.50% or less by weight of Mg. In the preparation of the high-thermal conductivity composite material, an as-cast AlNp/ZA27 composite material is subjected to homogenizing annealing and reciprocating extrusion.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 11, 2024
    Inventors: Shengqiang MA, Ping LV, Xudong CUI, Yusheng LIU, Xuebin HE, Jiaxu CHEN, Jiankang ZHANG, Jiandong XING, Wenmin NIU
  • Publication number: 20140194531
    Abstract: Hydroxytyrosol or olive juice containing hydroxytyrosol ca in can he used to maintain or increase mitochondria(biogenesis in cardiac muscle, skeletal muscles, and liver tissue.
    Type: Application
    Filed: January 6, 2014
    Publication date: July 10, 2014
    Applicant: DSM IP Assets B.V.
    Inventors: Jiankang LIU, Daniel RAEDERSTORFF, Ying WANG-SCHMIDT, Karin WERTZ
  • Publication number: 20120302645
    Abstract: The use of hydroxytyrosol or an olive juice extract containing hydroxytyrosol for improving muscle differentiation and thus improving or maintaining the body's adaptation to exercise is disclosed. The pharmaceutical and nutraceutical compositions comprising hydroxytyrosol useful for conditions characterized by altered muscle differentiation especially under inflammatory conditions, such as delayed onset muscle soreness subsequent to strenuous exercise or sarcopenia are provided.
    Type: Application
    Filed: October 8, 2010
    Publication date: November 29, 2012
    Inventors: Jiankang Liu, Ying Wang-Schmidt, Karin Wertz, Zhihui Feng
  • Publication number: 20110112201
    Abstract: Hydroxytyrosol or olive juice containing hydroxytyrosol can be used to maintain or increase mitochondrial biogenesis in cardiac muscle, skeletal muscles, and liver tissue.
    Type: Application
    Filed: April 17, 2009
    Publication date: May 12, 2011
    Inventors: Jiankang Liu, Daniel Raederstorff, Ying Wang-Schmidt, Karin Wertz
  • Publication number: 20100130620
    Abstract: The present invention is directed to the use of (a composition comprising) hydroxytyrosol for treating or preventing age-related macular degeneration in humans, for maintaining the eye health in animals (preferably in humans), especially in elderly animals (preferably elderly humans), for improving the vision of animals (preferably of humans), for maintaining the high resolution vision in animals (preferably in humans) and/or for maintaining the visual acuity in animals (preferably in humans), as well as for maintaining the visual performance in animals (preferably in humans) and/or the visual function in animals (preferably in humans).
    Type: Application
    Filed: April 18, 2007
    Publication date: May 27, 2010
    Inventors: Jiankang Liu, Wolfgang Schalch, Ying Wang-Schmidt, Karin Wertz
  • Publication number: 20060257502
    Abstract: A dietary supplement of mitochondrial nutrients is designed for relieving stress, preventing and improving stress-related disorders, such as chronic fatigue syndrome, diabetes, age-associated cognitive dysfunction and diseases (Parkinson's and Alzheimer's disease). The supplement composition has the following nutrients: B vitamins (cyanocobalamin 2-1,000 ug, thiamin 1-1,000 mg, niacin 15-2,000 mg, pyridoxine 1-1,000 mg, Pantothenate 5-150 mg, folic acid 400-40,000 ug), alpha-tocopherol 10-800 mg, ascorbic acid 50-10,000 mg, calcium 20-2,000 mg, vitamin A 200-10,000 ug, alpha-lipoic acid 100-1,000 mg, N-acetyl cysteine 100-3,000 mg, L-carnosine 100-9,000 mg, tyrosine 100-9,000 mg, vanillin 10-100 mg, phosphatidylserine 10-800 mg, resveratrol 10-50 mg, dehydroepiandrosterone 1-50 mg, and melatonin 0.
    Type: Application
    Filed: May 11, 2005
    Publication date: November 16, 2006
    Inventor: Jiankang Liu